Cargando…

Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy

Hyposalivation and sensation of dry mouth (xerostomia) are one of the most common adverse effects in the treatment of patients with head and neck cancer. OBJECTIVE: This study evaluates the prevalence of late hyposalivation and associated factors in survivors of squamous cell carcinoma of the oral c...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Riéli Elis, Bonzanini, Laura Izabel Lampert, Ortigara, Gabriela Barbieri, Soldera, Eloisa Barbieri, Danesi, Cristiane Cademartori, Antoniazzi, Raquel Pippi, Ferrazzo, Kívia Linhares
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade De Odontologia De Bauru - USP 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075291/
https://www.ncbi.nlm.nih.gov/pubmed/33886946
http://dx.doi.org/10.1590/1678-7757-2020-0854
_version_ 1783684514291122176
author Schulz, Riéli Elis
Bonzanini, Laura Izabel Lampert
Ortigara, Gabriela Barbieri
Soldera, Eloisa Barbieri
Danesi, Cristiane Cademartori
Antoniazzi, Raquel Pippi
Ferrazzo, Kívia Linhares
author_facet Schulz, Riéli Elis
Bonzanini, Laura Izabel Lampert
Ortigara, Gabriela Barbieri
Soldera, Eloisa Barbieri
Danesi, Cristiane Cademartori
Antoniazzi, Raquel Pippi
Ferrazzo, Kívia Linhares
author_sort Schulz, Riéli Elis
collection PubMed
description Hyposalivation and sensation of dry mouth (xerostomia) are one of the most common adverse effects in the treatment of patients with head and neck cancer. OBJECTIVE: This study evaluates the prevalence of late hyposalivation and associated factors in survivors of squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx treated with radiotherapy with or without concomitant chemotherapy. METHODOLOGY: A cross-sectional study was conducted with 88 patients who had concluded radiotherapy at least three months before the study, at a referral center for the treatment of head and neck cancer in the Southern region of Brazil. Hyposalivation was evaluated based on the stimulated salivary flow rate using the spitting method. Multivariate analysis using binary logistic regression was performed to determine the associations between hyposalivation and clinical and demographic variables. RESULTS: Hyposalivation was found in 78.41% of the sample and the mean radiation dose was 63.01 Gy (±9.58). In the crude model of the multivariate analysis, hyposalivation was associated with higher doses of radiation (p=0.038), treatment with concomitant radiotherapy and chemotherapy (p=0.005), and time elapsed since the end of radiotherapy (p=0.025). In the adjusted model of the multivariate analysis, hyposalivation was only associated with dose and time elapsed. Patient who received higher doses of radiation had a 4.25-fold greater chance of presenting hyposalivation, whereas a longer time elapsed since the end of radiotherapy exerted a 75% protective effect against the occurrence of hyposalivation. CONCLUSION: Hyposalivation is a highly prevalence late-onset side effect of radiotherapy in patients treated for head and neck cancer, with a greater chance of occurrence among those who received higher doses of radiation and those who ended therapy less than 22 months before our study. Concomitant chemotherapy and radiotherapy does not seem to increase the chances of hyposalivation compared to radiotherapy alone.
format Online
Article
Text
id pubmed-8075291
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Faculdade De Odontologia De Bauru - USP
record_format MEDLINE/PubMed
spelling pubmed-80752912021-04-30 Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy Schulz, Riéli Elis Bonzanini, Laura Izabel Lampert Ortigara, Gabriela Barbieri Soldera, Eloisa Barbieri Danesi, Cristiane Cademartori Antoniazzi, Raquel Pippi Ferrazzo, Kívia Linhares J Appl Oral Sci Original Article Hyposalivation and sensation of dry mouth (xerostomia) are one of the most common adverse effects in the treatment of patients with head and neck cancer. OBJECTIVE: This study evaluates the prevalence of late hyposalivation and associated factors in survivors of squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx treated with radiotherapy with or without concomitant chemotherapy. METHODOLOGY: A cross-sectional study was conducted with 88 patients who had concluded radiotherapy at least three months before the study, at a referral center for the treatment of head and neck cancer in the Southern region of Brazil. Hyposalivation was evaluated based on the stimulated salivary flow rate using the spitting method. Multivariate analysis using binary logistic regression was performed to determine the associations between hyposalivation and clinical and demographic variables. RESULTS: Hyposalivation was found in 78.41% of the sample and the mean radiation dose was 63.01 Gy (±9.58). In the crude model of the multivariate analysis, hyposalivation was associated with higher doses of radiation (p=0.038), treatment with concomitant radiotherapy and chemotherapy (p=0.005), and time elapsed since the end of radiotherapy (p=0.025). In the adjusted model of the multivariate analysis, hyposalivation was only associated with dose and time elapsed. Patient who received higher doses of radiation had a 4.25-fold greater chance of presenting hyposalivation, whereas a longer time elapsed since the end of radiotherapy exerted a 75% protective effect against the occurrence of hyposalivation. CONCLUSION: Hyposalivation is a highly prevalence late-onset side effect of radiotherapy in patients treated for head and neck cancer, with a greater chance of occurrence among those who received higher doses of radiation and those who ended therapy less than 22 months before our study. Concomitant chemotherapy and radiotherapy does not seem to increase the chances of hyposalivation compared to radiotherapy alone. Faculdade De Odontologia De Bauru - USP 2021-04-19 /pmc/articles/PMC8075291/ /pubmed/33886946 http://dx.doi.org/10.1590/1678-7757-2020-0854 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Schulz, Riéli Elis
Bonzanini, Laura Izabel Lampert
Ortigara, Gabriela Barbieri
Soldera, Eloisa Barbieri
Danesi, Cristiane Cademartori
Antoniazzi, Raquel Pippi
Ferrazzo, Kívia Linhares
Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy
title Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy
title_full Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy
title_fullStr Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy
title_full_unstemmed Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy
title_short Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy
title_sort prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075291/
https://www.ncbi.nlm.nih.gov/pubmed/33886946
http://dx.doi.org/10.1590/1678-7757-2020-0854
work_keys_str_mv AT schulzrielielis prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy
AT bonzaninilauraizabellampert prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy
AT ortigaragabrielabarbieri prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy
AT solderaeloisabarbieri prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy
AT danesicristianecademartori prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy
AT antoniazziraquelpippi prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy
AT ferrazzokivialinhares prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy